Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neumora Therapeutics Inc (NMRA)

Neumora Therapeutics Inc (NMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 208,655
  • Shares Outstanding, K 161,748
  • Annual Sales, $ 0 K
  • Annual Income, $ -243,790 K
  • EBIT $ -274 M
  • EBITDA $ -279 M
  • 60-Month Beta 2.75
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.75

Options Overview Details

View History
  • Implied Volatility 100.96% ( -38.22%)
  • Historical Volatility 117.55%
  • IV Percentile 11%
  • IV Rank 11.51%
  • IV High 604.03% on 04/16/25
  • IV Low 35.52% on 09/13/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 561
  • Volume Avg (30-Day) 171
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 11,295
  • Open Int (30-Day) 11,070

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.38
  • Number of Estimates 4
  • High Estimate -0.33
  • Low Estimate -0.44
  • Prior Year -0.37
  • Growth Rate Est. (year over year) -2.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7158 +80.22%
on 06/30/25
1.4100 -8.51%
on 07/11/25
+0.3683 (+39.96%)
since 06/11/25
3-Month
0.6110 +111.13%
on 05/14/25
1.4100 -8.51%
on 07/11/25
+0.6082 (+89.21%)
since 04/11/25
52-Week
0.6110 +111.13%
on 05/14/25
17.1874 -92.49%
on 10/18/24
-10.2600 (-88.83%)
since 07/11/24

Most Recent Stories

More News
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861

NMRA : 1.2900 (+21.70%)
Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

NMRA : 1.2900 (+21.70%)
Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

NMRA : 1.2900 (+21.70%)
Neumora Therapeutics to Present at Leerink Global Healthcare Conference

NMRA : 1.2900 (+21.70%)
Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

NMRA : 1.2900 (+21.70%)
Neumora Therapeutics Announces Leadership Transition

NMRA : 1.2900 (+21.70%)
Neumora Stock Hits Record Low on Depression Drug Study Failure

Shares of Neumora Therapeutics NMRA lost more than 80% on Thursday after reporting the failure of its lead pipeline drug, navacaprant, in a late-stage study for major depressive disorder (MDD).The phase...

CTMX : 2.42 (-6.92%)
CSTL : 19.66 (-0.91%)
NMRA : 1.2900 (+21.70%)
SPRO : 2.81 (-1.06%)
Stocks Settle Lower as Tesla and Apple Slump

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.17%. March E-mini...

MSTR : 434.58 (+3.04%)
MPC : 179.86 (-1.32%)
AAPL : 211.16 (-0.59%)
CVX : 155.31 (+0.74%)
NMRA : 1.2900 (+21.70%)
HR : 16.10 (-0.56%)
$IUXX : 22,780.60 (-0.21%)
COIN : 387.06 (-0.49%)
ASML : 801.93 (-0.02%)
ZNU25 : 110-230s (-0.45%)
TSLA : 313.51 (+1.17%)
ESU25 : 6,300.00s (-0.38%)
Stocks Push Higher as Chip Makers and Energy Producers Climb

The S&P 500 Index ($SPX ) (SPY ) today is up +0.35%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.36%. March E-mini S&P futures (ESH25...

MSTR : 434.58 (+3.04%)
AMAT : 197.93 (-0.05%)
MPC : 179.86 (-1.32%)
AAPL : 211.16 (-0.59%)
AVGO : 274.38 (-0.37%)
CVX : 155.31 (+0.74%)
SLB : 37.31 (+1.80%)
NMRA : 1.2900 (+21.70%)
HR : 16.10 (-0.56%)
$IUXX : 22,780.60 (-0.21%)
COIN : 387.06 (-0.49%)
ASML : 801.93 (-0.02%)
Stocks Climb on Strength in Chip Stocks and Energy Producers

The S&P 500 Index ($SPX ) (SPY ) today is up +0.72%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.81%. March E-mini S&P futures (ESH25...

MSTR : 434.58 (+3.04%)
MPC : 179.86 (-1.32%)
AAPL : 211.16 (-0.59%)
AVGO : 274.38 (-0.37%)
CVX : 155.31 (+0.74%)
ADI : 244.68 (-0.19%)
SLB : 37.31 (+1.80%)
NMRA : 1.2900 (+21.70%)
HR : 16.10 (-0.56%)
$IUXX : 22,780.60 (-0.21%)
COIN : 387.06 (-0.49%)
ASML : 801.93 (-0.02%)

Business Summary

Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. Its therapeutic pipeline currently consists of clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Neumora...

See More

Key Turning Points

3rd Resistance Point 1.8593
2nd Resistance Point 1.6347
1st Resistance Point 1.4623
Last Price 1.2900
1st Support Level 1.0653
2nd Support Level 0.8407
3rd Support Level 0.6683

See More

52-Week High 17.1874
Fibonacci 61.8% 10.8552
Fibonacci 50% 8.8992
Fibonacci 38.2% 6.9432
Last Price 1.2900
52-Week Low 0.6110

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar